• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 37 páginas
Examen

NURS 5359 Exam 1 Antipsychotic Medications 2026 | 200 Practice Questions with Correct Answers & Detailed Rationales | Nursing Pharmacology Study Guide

Document preview thumbnail
Vista previa 4 fuera de 37 páginas

Master NURS 5359 Exam 1 – Antipsychotic Medications with this comprehensive 200-question nursing study resource featuring practice questions, correct answers, and detailed rationales. Designed to help nursing students strengthen their understanding of antipsychotic pharmacology, medication safety, adverse effects, clinical monitoring, and patient education while preparing for exams and course assessments. This study guide focuses on the key concepts students need to recognize when studying typical and atypical antipsychotic medications, including mechanisms of action, therapeutic effects, adverse reactions, contraindications, drug interactions, monitoring requirements, and nursing interventions. KEY TOPICS COVERED Typical/first-generation antipsychotics Atypical/second-generation antipsychotics Antipsychotic mechanisms of action Dopamine and serotonin receptor activity Therapeutic uses of antipsychotic medications Schizophrenia and psychotic disorders Positive and negative symptoms Extrapyramidal symptoms (EPS) Acute dystonia Akathisia Parkinsonism Tardive dyskinesia Neuroleptic malignant syndrome (NMS) Anticholinergic adverse effects Orthostatic hypotension Sedation and CNS effects Metabolic adverse effects Weight gain and metabolic monitoring Hyperglycemia and dyslipidemia QT prolongation and cardiac considerations Agranulocytosis and blood monitoring Clozapine safety considerations Antipsychotic medication interactions Medication administration and adherence Long-acting injectable antipsychotics Patient and family education Nursing assessments and interventions Medication safety and clinical monitoring Priority nursing considerations Exam-style clinical scenarios WHY THIS STUDY RESOURCE IS USEFUL 200 practice questions: Provides extensive practice for NURS 5359 Exam 1 preparation. Correct answers included: Helps students check their understanding after attempting each question. Detailed rationales: Explains the clinical reasoning behind the answers instead of relying on memorization alone. Antipsychotic-focused: Concentrates specifically on the medication concepts relevant to the exam topic. Nursing-focused review: Connects pharmacology concepts with assessment, monitoring, patient education, and nursing interventions. Clinical scenario practice: Helps reinforce recognition of adverse effects and appropriate nursing responses. Efficient exam preparation: Useful for reviewing major concepts and identifying areas that require additional study. Comprehensive coverage: Includes both first-generation and second-generation antipsychotic medications and their important safety considerations. Important: This is an independently prepared study/practice resource. It is not an official NURS 5359 examination, leaked exam, confidential course material, or a guarantee of a particular grade. Students should use their course materials, instructor guidance, and assigned textbook/resources as the authoritative sources for their course.

Vista previa del contenido

,NURS 5359 Exam 1 – Antipsychotic Medications | 200 Questions with
Accurate Answers and Rationales

SECTION 1: GENERAL CONCEPTS AND MECHANISMS (Questions 1–25)

1. Which neurotransmitter is primarily implicated in the therapeutic effects of antipsychotic
medications?
A. Serotonin
B. Dopamine
C. Norepinephrine
D. GABA
Answer: B
Rationale: Antipsychotics primarily work by blocking dopamine D2 receptors in the mesolimbic pathway,
reducing positive symptoms of psychosis.

2. The dopamine hypothesis of schizophrenia proposes that positive symptoms are related to:
A. Dopamine deficiency in the mesocortical pathway
B. Dopamine excess in the mesolimbic pathway
C. Serotonin excess in the brainstem
D. GABA deficiency in the cortex
Answer: B
Rationale: Positive symptoms (hallucinations, delusions) are linked to excessive dopamine activity in the
mesolimbic pathway.

3. Which antipsychotic is classified as a first-generation (typical) antipsychotic?
A. Risperidone
B. Olanzapine
C. Haloperidol
D. Quetiapine
Answer: C
Rationale: Haloperidol is a butyrophenone typical antipsychotic. The others are atypicals.

4. Which receptor blockade is most associated with extrapyramidal symptoms (EPS)?
A. Serotonin 5-HT2A
B. Dopamine D2 in the nigrostriatal pathway
C. Histamine H1
D. Muscarinic acetylcholine
Answer: B
Rationale: Blockade of D2 receptors in the nigrostriatal pathway causes EPS.

5. Atypical antipsychotics have a lower risk of EPS because they:
A. Block more D2 receptors
B. Block serotonin 5-HT2A and dopamine D2 with fast dissociation
C. Have no dopamine blockade
D. Increase dopamine release

,Answer: B
Rationale: Atypicals have higher 5-HT2A/D2 affinity ratios and fast dissociation from D2 receptors,
reducing EPS.

6. Which antipsychotic is most likely to cause agranulocytosis?
A. Haloperidol
B. Clozapine
C. Risperidone
D. Aripiprazole
Answer: B
Rationale: Clozapine carries a black box warning for severe neutropenia/agranulocytosis; requires
regular ANC monitoring.

7. The black box warning for all antipsychotics in elderly patients with dementia-related psychosis is:
A. Increased risk of falls
B. Increased risk of death (mostly cardiovascular or infectious)
C. Increased risk of diabetes
D. Increased risk of seizures
Answer: B
Rationale: All antipsychotics carry a boxed warning for increased mortality in elderly patients with
dementia-related psychosis.

8. Which antipsychotic is available as a long-acting injectable (LAI)?
A. Haloperidol decanoate
B. Clozapine
C. Quetiapine
D. Olanzapine (oral only)
Answer: A
Rationale: Haloperidol decanoate is a long-acting injectable. Olanzapine also has an LAI (Zyprexa
Relprevv), but the question asks “which is available” – haloperidol decanoate is correct.

9. Which laboratory test is mandatory before starting clozapine?
A. Liver function tests
B. Absolute neutrophil count (ANC)
C. Serum creatinine
D. Thyroid function
Answer: B
Rationale: Baseline ANC is required, and weekly monitoring for 6 months, then biweekly, then monthly.

10. Which side effect is most characteristic of typical antipsychotics?
A. Weight gain
B. Metabolic syndrome
C. Extrapyramidal symptoms
D. Hyperprolactinemia (less common)
Answer: C
Rationale: Typical antipsychotics commonly cause EPS due to strong D2 blockade.

, 11. Which atypical antipsychotic is most associated with weight gain and metabolic syndrome?
A. Ziprasidone
B. Aripiprazole
C. Olanzapine
D. Lurasidone
Answer: C
Rationale: Olanzapine has the highest risk of weight gain and metabolic disturbances among atypicals.

12. Which antipsychotic has the lowest risk of metabolic side effects?
A. Olanzapine
B. Clozapine
C. Ziprasidone
D. Quetiapine
Answer: C
Rationale: Ziprasidone is relatively weight-neutral and has lower metabolic risk.

13. Which medication is used to treat acute dystonia from antipsychotics?
A. Benztropine
B. Propranolol
C. Valbenazine
D. Lithium
Answer: A
Rationale: Benztropine (anticholinergic) or diphenhydramine is used for acute dystonia.

14. Tardive dyskinesia is characterized by:
A. Involuntary repetitive movements (lip smacking, tongue protrusion)
B. Muscle rigidity and fever
C. Tremor at rest
D. Akathisia
Answer: A
Rationale: Tardive dyskinesia involves involuntary choreoathetoid movements, often of the face and
tongue.

15. Which medication is approved for tardive dyskinesia?
A. Valbenazine
B. Haloperidol
C. Benztropine
D. Propranolol
Answer: A
Rationale: Valbenazine and deutetrabenazine are VMAT2 inhibitors approved for TD.

16. Neuroleptic malignant syndrome (NMS) is characterized by:
A. Hyperthermia, muscle rigidity, autonomic instability, altered mental status
B. Hypothermia, flaccidity, bradycardia
C. Hypertension, tachycardia, diarrhea
D. Weight gain, hyperglycemia

Información del documento

Subido en
28 de septiembre de 2026
Número de páginas
37
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$21.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
itsjustel
4.7
(3)
Vendido
31
Seguidores
1
Artículos
827
Última venta
23 horas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes